Known targets — ChEMBL curated mechanism
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
The experimentally established mechanism targets of Phosphoric Acid. The predicted profile below is derived independently by chemical similarity — agreement is a validation signal, a miss is honest.
Predicted protein targets (top 4)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | TP53 | P04637 | 1/20 | 0.56 |
| ▸ | SLC34A1 | Q06495 | 1/20 | 0.35 |
| ▸ | LMNA | P02545 | 2/20 | 0.32 |
| ▸ | TYMS | P04818 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Phosphoric Acid SCHEMBL11590142 | 0.97 | TP53 (0.53) | TP53SLC34A1LMNA | |
| Phosphoric Acid SCHEMBL20610254 | 0.97 | TP53 (0.53) | TP53SLC34A1LMNA | |
| Phosphoric Acid SCHEMBL11047641 | 0.90 | TP53 (0.53) | TP53SLC34A1LMNA | |
| Phosphoric Acid SCHEMBL20610167 | 0.90 | TP53 (0.53) | TP53SLC34A1LMNA | |
| Phosphoric Acid SCHEMBL6739275 | 0.86 | TP53 (0.43) | TP53LMNA | |
| Phosphoric Acid SCHEMBL3976734 | 0.76 | SLC34A1 (0.33) | TP53SLC34A1LMNA | |
| Bicarbonate SCHEMBL2938935 | 0.74 | TP53 (0.59) | TP53LMNA | |
| Glycerin SCHEMBL15463836 | 0.73 | LMNA (0.56) | TP53SLC34A1LMNA | |
| Glycerin SCHEMBL5161896 | 0.73 | LMNA (0.56) | TP53SLC34A1LMNA | |
| Glycerin SCHEMBL1134753 | 0.73 | LMNA (0.56) | TP53SLC34A1LMNA |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 301 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-3980508-B1 | COMPOSITION FOR ENHANCING INJECTIVITY OF A SUBTERRANEAN FORMATION | TOTALENERGIES ONETECH (FR) | 2025-03-19 | — | — | EP | claimed |
| EP-3387088-B1 | WELL-TREATMENT FLUIDS COMPOSITION | ENERGY SOLUTIONS US LLC (US) | 2025-03-05 | — | — | EP | claimed |
| US-12091608-B2 | Composition for enhancing injectivity of a subterranean formation | TOTALENERGIES ONETECH (FR) | 2024-09-17 | — | — | US | claimed |
| US-11987661-B2 | Modified polymer polyols | REPSOL, S.A. (ES) | 2024-05-21 | — | — | US | claimed |
| EP-3317365-B1 | MICROBIAL VISCOSITY BREAKER COMPOSITIONS | ENERGY SOLUTIONS US LLC (US) | 2023-09-06 | — | — | EP | claimed |
| US-11419333-B2 | Compositions and methods for biofilm removal | CHAMPIONX USA INC. (US) | 2022-08-23 | — | — | US | claimed |
| US-20220220359-A1 | Composition for Enhancing Injectivity of a Subterranean Formation | TOTALENERGIES ONETECH (FR) | 2022-07-14 | — | — | US | claimed |
| US-11377588-B2 | Well treatment fluids composition | SOLVAY USA INC. (US) | 2022-07-05 | — | — | US | claimed |
| EP-3980508-A1 | COMPOSITION FOR ENHANCING INJECTIVITY OF A SUBTERRANEAN FORMATION | TotalEnergies SE (FR) | 2022-04-13 | — | — | EP | claimed |
| EP-3649164-B1 | MODIFIED POLYMER POLYOLS | REPSOL SA (ES) | 2021-09-08 | — | — | EP | claimed |
| WO-2005123607-A1 | IMPROVEMENT OF SLUDGE QUALITY | RHODIA UK LIMITED (GB) | 2005-12-29 | — | — | WO | claimed |
| WO-2005079578-A2 | EMBEDDED BIOCIDE | RHODIA UK LIMITED (GB) | 2005-09-01 | — | — | WO | claimed |
| WO-2004113236-A2 | UNCOUPLING AGENTS | RHODIA UK LTD (GB) | 2004-12-29 | — | — | WO | claimed |
| WO-2004113237-A1 | TREATMENT OF SEWAGE SLUDGE | RHODIA UK LTD (GB) | 2004-12-29 | — | — | WO | claimed |
| WO-2004104367-A1 | SLUDGE CONTROL IN CRUDE OIL | RHODIA CONSUMER SPECIALTIES LIMITED (GB) | 2004-12-02 | — | — | WO | claimed |
| EP-1098566-A1 | SYNERGISTIC ANTIMICROBIAL COMPOSITION OF PEROXYACETIC ACID AND A PHOSPHOROUS COMPOUND | Calgon Corporation (US) | 2001-05-16 | — | — | EP | claimed |
| WO-2000004777-A1 | SYNERGISTIC ANTIMICROBIAL COMPOSITION OF PEROXYACETIC ACID AND A PHOSPHORUS COMPOUND | CALGON CORPORATION (US) | 2000-02-03 | — | — | WO | claimed |
| US-4673509-A | ADDING PHOSPHONIUM COMPOUND | ALBRIGHT & WILSON LIMITED (GB) | 1987-06-16 | — | — | US | claimed |
| US-4066391-A | UREA OR CONDENSATE AND PHOSPHONIUM SALT CURE | AMERICAN CYANAMID COMPANY (US) | 1978-01-03 | — | — | US | claimed |
| US-4026711-A | TETRAKIS(HYDROXYMETHYL)PHOSPHONIUM PHOSPHATE-CARBOXYLATE, UREA | AMERICAN CYANAMID COMPANY (US) | 1977-05-31 | — | — | US | claimed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-11419333-B2 | Compositions and methods for biofilm removal | ALG1, FUT5, FUT6 | TP53 4628/4885SLC34A1 1997/4885LMNA 1407/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.